{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:30:26Z","timestamp":1760783426686},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s10822-011-9456-7","type":"journal-article","created":{"date-parts":[[2011,7,21]],"date-time":"2011-07-21T12:04:38Z","timestamp":1311249878000},"page":"689-698","source":"Crossref","is-referenced-by-count":17,"title":["Novel isoquinolone PDK1 inhibitors discovered through fragment-based lead discovery"],"prefix":"10.1007","volume":"25","author":[{"given":"M. Catherine","family":"Johnson","sequence":"first","affiliation":[]},{"given":"Qiyue","family":"Hu","sequence":"additional","affiliation":[]},{"given":"Laura","family":"Lingardo","sequence":"additional","affiliation":[]},{"given":"Rose Ann","family":"Ferre","sequence":"additional","affiliation":[]},{"given":"Samantha","family":"Greasley","sequence":"additional","affiliation":[]},{"given":"Jiangli","family":"Yan","sequence":"additional","affiliation":[]},{"given":"John","family":"Kath","sequence":"additional","affiliation":[]},{"given":"Ping","family":"Chen","sequence":"additional","affiliation":[]},{"given":"Jacques","family":"Ermolieff","sequence":"additional","affiliation":[]},{"given":"Gordon","family":"Alton","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2011,7,22]]},"reference":[{"key":"9456_CR1","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nrd1467","volume":"3","author":"DC Rees","year":"2004","unstructured":"Rees DC, Congreve M, Murray CW, Carr R (2004) Fragment-based lead discovery. Nat Rev Drug Discov 3:660\u2013672","journal-title":"Nat Rev Drug Discov"},{"key":"9456_CR2","volume-title":"Fragment-based approaches in drug discovery","year":"2006","unstructured":"Jahnke W, Erlanson DA (eds) (2006) Fragment-based approaches in drug discovery. Wiley, New York"},{"key":"9456_CR3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrd2220","volume":"6","author":"PJ Hajduk","year":"2007","unstructured":"Hajduk PJ, Greer J (2007) A decade of fragment-based drug design: strategic advances and lessons learned. Nat Rev Drug Discov 6:211\u2013219","journal-title":"Nat Rev Drug Discov"},{"key":"9456_CR4","unstructured":"Congreve M, Murray CW, Carr R, Rees DC (2007) Fragment-based lead discovery. In: Macor JE (ed) Annual Reports in Medicinal Chemistry 42:431\u2013448"},{"key":"9456_CR5","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1021\/jm8000373","volume":"51","author":"M Congreve","year":"2008","unstructured":"Congreve M, Chessari G, Tisi D, Woodhead AJ (2008) Recent developments in fragment-based drug discovery. J Med Chem 51:3661\u20133680","journal-title":"J Med Chem"},{"key":"9456_CR6","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S1359-6446(04)03069-7","volume":"9","author":"AL Hopkins","year":"2004","unstructured":"Hopkins AL, Groom CR, Alex A (2004) Ligand efficiency: a useful metric for lead selection. Drug Discov Today 9:430\u2013431","journal-title":"Drug Discov Today"},{"key":"9456_CR7","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/cmdc.200800195","volume":"3","author":"C Peifer","year":"2008","unstructured":"Peifer C, Alessi DR (2008) Small-molecule inhibitors of PDK1. Chem Med Chem 3:1810\u20131838","journal-title":"Chem Med Chem"},{"key":"9456_CR8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.semcdb.2003.12.022","volume":"15","author":"A Mora","year":"2004","unstructured":"Mora A, Komander D, van Aalten DMF, Alessi DR (2004) PDK1, the master regulator of AGC kinase signal transduction. Cell Dev Biol 15:161\u2013170","journal-title":"Cell Dev Biol"},{"key":"9456_CR9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0092-8674(00)00110-0","volume":"103","author":"A Toker","year":"2000","unstructured":"Toker A, Newton AC (2000) Cellular signaling: pivoting around PDK-1. Cell 103:185\u2013188","journal-title":"Cell"},{"key":"9456_CR10","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.cub.2005.08.066","volume":"15","author":"JR Bayascas","year":"2005","unstructured":"Bayascas JR, Leslie NR, Parsons R, Fleming S, Alessi DR (2005) Hypomorphic mutation of PDK1 suppresses tumorigenesis in PTEN+\/- Mice. Curr Biol 15:1839\u20131846","journal-title":"Curr Biol"},{"key":"9456_CR11","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1016\/j.bmcl.2010.05.070","volume":"20","author":"M Angiolini","year":"2010","unstructured":"Angiolini M, Banfi P, Casale E, Casuscelli F, Fiorelli C, Saccardo MB, Silvagni M, Zuccotto F (2010) Structure-based optimization of potent PDK1 inhibitors. Bioorg Med Chem Lett 20:4095\u20134099","journal-title":"Bioorg Med Chem Lett"},{"key":"9456_CR12","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.ejmech.2009.12.036","volume":"45","author":"T Nittoli","year":"2010","unstructured":"Nittoli T, Dushin RG, Ingalls C, Cheung K, Floyd MB, Fraser H, Olland A, Hu Y, Grosu G, Han X, Arndt K, Guo B, Wissner A (2010) The identification of 8, 9-dimethoxy-5-(2-aminoalkoxy-pyridin-3-yl)-benzo[c][2,7]naphthyridin-4-ylamines as potent inhibitors of 3-phosphoinositide-dependent kinase-1 (PDK-1). Eur J Med Chem 45:1379\u20131386","journal-title":"Eur J Med Chem"},{"key":"9456_CR13","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.bmcl.2007.12.018","volume":"18","author":"F Stauffer","year":"2008","unstructured":"Stauffer F, Maira S-M, Furet P, Garc\u00eda-Echeverr\u00eda C (2008) Imidazo[4,5-c]quinolines as inhibitors of the PI3K\/PKB-pathway. Bioorg Med Chem Lett 18:1027\u20131030","journal-title":"Bioorg Med Chem Lett"},{"key":"9456_CR14","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.2174\/156802607782341109","volume":"7","author":"RE Hubbard","year":"2007","unstructured":"Hubbard RE, Davis B, Chen I, Drysdale MJ (2007) The seeds approach: integrating fragments into drug discovery. Curr Top Med Chem 7:1568\u20131581","journal-title":"Curr Top Med Chem"},{"key":"9456_CR15","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1021\/ml100136n","volume":"1","author":"JR Medina","year":"2010","unstructured":"Medina JR, Blackledge CW, Heerding DA, Campobasso N, Ward P, Briand J, Wright L, Axten JM (2010) Aminoindazole PDK1 Inhibitors: a case study in fragment-based drug discovery. ACS Med Chem Lett 1:439\u2013442","journal-title":"ACS Med Chem Lett"},{"key":"9456_CR16","doi-asserted-by":"crossref","unstructured":"Medina JR, Becker CJ, Blackledge CW, Duquenne C, Feng Y, Grant SW, Heerding D, Li WH, Miller WH, Romeril SP, Scherzer D, Shu A, Bobko MA, Chadderton AR, Dumble M, Gardiner CM, Gilbert S, Liu Q, Rabindran SK, Sudakin V, Xiang H, Brady PG, Campobasso N, Ward P, Axten JM (2011) Structure-based design of potent and selective 3-phosphoinositide-dependent kinase-1 (PDK1) inhibitors. J Med Chem 54:1871\u20131895","DOI":"10.1021\/jm101527u"},{"key":"9456_CR17","doi-asserted-by":"crossref","unstructured":"Erlanson DA, Arndt JW, Cancilla MT, Cao K, Elling RA, English N, Friedman J, Hansen SK, Hession C, Joseph I, Kumaravel G, Lee W-C, Lind KE, McDowell RS, Miatkowski K, Nguyen C, Nguyen TB, Park S, Pathan N, Penny DM, Romanowski MJ, Scott D, Silvian L, Simmons RL, Tangonan BT, Yang W, Sun L (2011) Discovery of a potent and highly selective PDK1 inhibitor via fragment-based drug discovery. Bioorg Med Chem Lett 21:3078\u20133083","DOI":"10.1016\/j.bmcl.2011.03.032"},{"key":"9456_CR18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1747-0285.2008.00768.x","volume":"73","author":"BJ Stockman","year":"2009","unstructured":"Stockman BJ, Kothe M, Kohls D, Weibley L, Connolly BJ, Sheils AL, Cao Q, Cheng AC, Yang L, Kamath AV, Ding Y-H, Charlton ME (2009) Identification of allosteric PIF-pocket ligands for PDK1 using NMR-based fragment screening and 1H\u201315N TROSY experiments. Chem Biol Drug Des 73:179\u2013188","journal-title":"Chem Biol Drug Des"},{"key":"9456_CR19","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q","volume":"38","author":"M Mayer","year":"1999","unstructured":"Mayer M, Meyer B (1999) Characterization of ligand binding by saturation transfer difference NMR spectroscopy. Angew Chem Int Ed 38:1784\u20131788","journal-title":"Angew Chem Int Ed"},{"key":"9456_CR20","unstructured":"http:\/\/accelrys.com\/products\/datasheets\/accord-chemistry-cartridge.pdf"},{"key":"9456_CR21","doi-asserted-by":"crossref","first-page":"6972","DOI":"10.1021\/jm060511h","volume":"49","author":"PJ Hajduk","year":"2006","unstructured":"Hajduk PJ (2006) Fragment-based drug design: how big is too big? J Med Chem 49:6972\u20136976","journal-title":"J Med Chem"},{"key":"9456_CR22","unstructured":"Pipeline Pilot from Accelrys: http:\/\/www.accelrys.com\/"},{"key":"9456_CR23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/1074-5521(95)90050-0","volume":"2","author":"DK Gehlhaar","year":"1995","unstructured":"Gehlhaar DK, Verkhivker GM, Rejto PA, Sherman CJ, Fogel DB, Fogel LJ, Freer ST (1995) Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: conformationally flexible docking by evolutionary programming. Chem Biol 2:317\u2013324","journal-title":"Chem Biol"},{"key":"9456_CR24","doi-asserted-by":"crossref","unstructured":"Gehlhaar DK, Bouzida D, Rejto PA (1999) Reduced dimensionality in ligand-protein structure prediction: covalent inhibitors of serine proteases and design of site-directed combinatorial libraries. In: Parrill AL, Reddy MR (eds) Rational drug design: novel methodology and practical applications. ACS Symposium Series, ACS Press, New York, 719:292\u2013311","DOI":"10.1021\/bk-1999-0719.ch019"},{"key":"9456_CR25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1023\/A:1008741308684","volume":"20","author":"TJ Marrone","year":"2000","unstructured":"Marrone TJ, Luty BA, Rose PW (2000) Discovering high-affinity ligands from the computationally predicted structures and affinities of small molecules bound to a target: a virtual screening approach. Perspect Drug Discov Des 20:209\u2013230","journal-title":"Perspect Drug Discov Des"},{"key":"9456_CR26","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1021\/jm061066t","volume":"50","author":"PV Fish","year":"2007","unstructured":"Fish PV, Barber CG, Brown DG, Butt R, Collis MG, Dickinson RP, Henry BT, Horne VA, Huggins JP, King E, O\u2019Gara M, McCleverty D, McIntosh F, Phillips C, Webster R (2007) Selective urokinase-type plasminogen activator inhibitors. 4.1-(7-Sulfonamidoisoquinolinyl)guanidines. J Med Chem 50:2341\u20132351","journal-title":"J Med Chem"},{"key":"9456_CR27","doi-asserted-by":"crossref","unstructured":"Lau WF, Withka JM, Hepworth D, Magee TV, Du YJ, Bakken GA, Miller MD, Hendsch ZS, Thanabal V, Kolodziej SA, Xing L, Hu Q, Narasimhan LS, Love R, Charlton ME, Hughes S, Van Hoorn WP, Mills JE (2011) Design of a multi-purpose fragment screening library using molecular complexity and orthogonal diversity metrics. J Comput-Aided Mol Des (in press)","DOI":"10.1007\/s10822-011-9434-0"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-011-9456-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10822-011-9456-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-011-9456-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T05:12:28Z","timestamp":1560402748000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10822-011-9456-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["9456"],"URL":"https:\/\/doi.org\/10.1007\/s10822-011-9456-7","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}